Citigroup
YARW

Citigroup’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Citigroup’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-44
Closed -$16K – 6360
2022
Q2 		$16K Buy
44
+43
+4,300% +$18K ﹤0.01% 5133
2022
Q1 		$1K Buy
+1
New +$594 ﹤0.01% 6224
2021
Q4 		– Sell
-3
Closed -$4K – 6111
2021
Q3 		$4K Hold
3
– – ﹤0.01% 5619
2021
Q2 		$11K Sell
3
-163
-98% -$645K ﹤0.01% 5635
2021
Q1 		$1.02M Buy
166
+157
+1,744% +$1.14M ﹤0.01% 2971
2020
Q4 		$52K Buy
9
+7
+350% +$44K ﹤0.01% 6018
2020
Q3 		$12K Sell
2
-2
-50% -$11.7K ﹤0.01% 6519
2020
Q2 		$25K Hold
4
– – ﹤0.01% 6455
2020
Q1 		$40K Buy
4
+3
+300% +$47.1K ﹤0.01% 6182
2019
Q4 		$17K Buy
+1
New +$16.7K ﹤0.01% 7002
2019
Q3 		– Sell
-1
Closed -$16.1K – 7229
2019
Q2 		$24K Hold
1
– – ﹤0.01% 6998
2019
Q1 		$19K Hold
1
– – ﹤0.01% 6996
2018
Q4 		$10K Hold
1
– – ﹤0.01% 7163
2018
Q3 		$26K Buy
+1
New +$30.9K ﹤0.01% 6963
2018
Q2 		– Hold
0
– – – 7198
2018
Q1 		– Hold
0
– – – 6469

Other funds holding YARW

DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Citigroup's YARW Position: Q3 2022 in Review

Citigroup sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2022, closing a stake of 44 shares — an estimated $16K sold.

Citigroup first reported a position in YARW in Q3 2018 and held it in 14 quarters. The position peaked at $1.02M in Q1 2021. 37 funds tracked by Wall St. Rank hold YARW as of Q3 2022.

  • Citigroup reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 44 Yarrow Bioscience, Inc. Common Stock shares in Q3 2022, an estimated $16K.
  • Citigroup first reported a position in Yarrow Bioscience, Inc. Common Stock in Q3 2018 and held it in 14 quarters.
  • Citigroup's Yarrow Bioscience, Inc. Common Stock position peaked at $1.02M in Q1 2021.
  • 37 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.